Lenalidomide for the durham VAMC for patient care
Active Awarded Last action
- Contract number
- 36C24626N0416
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $4,548,792
Award facts
- Contract value 100% obligated
- $4,548,792.08 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a $4.55 million delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide to support patient care at the Durham Veterans Affairs Medical Center. The contract is structured as a firm fixed-price delivery order, with an ultimate completion date of January 14, 2027, issued without a set-aside designation. Exelan Pharmaceuticals, a Boca Raton, Florida-based pharmaceutical manufacturing and distribution company, will perform substantially all work at its primary facility. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which provides a pre-competed procurement framework for pharmaceutical products across federal agencies.
This delivery order represents part of Exelan's ongoing strategic role as a key pharmaceutical supplier to the VA healthcare system, particularly for oncology and hematologic malignancy treatments. Exelan maintains an extensive portfolio of indefinite delivery contracts and blanket purchase agreements with the VA National Acquisition Center and other federal agencies, with individual contract ceilings ranging from approximately $12.8 million to $88.2 million across various medications. The company operates as a prime contractor with no identified major subcontractors and has demonstrated capability to fulfill large-scale pharmaceutical supply requirements across multiple therapeutic categories for the VA, Department of Defense, Bureau of Prisons, and Indian Health Service.
Quick answers
Who was awarded contract 36C24626N0416?
36C24626N0416 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C24626N0416 worth?
The government has obligated $4,548,792 on 36C24626N0416.
Is contract 36C24626N0416 an order under another contract?
Yes. 36C24626N0416 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0416 competed?
The extent of competition for 36C24626N0416 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award